Payment overview · 2025
General Payments
$14,159.97
131 reported records · 14 companies
Healthcare provider profile · identity verified
John Phair, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · LONG ISLAND CITY, NY · NPI 1033539705
Verified facts
What the public records show
CMS Open Payments records show John Phair, MD received $14,159.97 in general payments during 2025 across 131 reported records.
Stryker Corporation accounted for 33.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 35 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $4,718.58 | 33.3% | 13 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $2,292.93 | 16.2% | 15 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $2,292.52 | 16.2% | 15 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $1,422.56 | 10.1% | 40 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$1,023.11 | 7.2% | 12 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $614.15 | 4.3% | 9 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $450.00 | 3.2% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $418.93 | 3.0% | 12 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $299.02 | 2.1% | 4 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $214.09 | 1.5% | 3 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $190.64 | 1.4% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $114.65 | 0.8% | 4 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $89.28 | 0.6% | 1 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $19.51 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $8,337.00 | 123 |
| Consulting Fee | $4,250.00 | 3 |
| Travel and Lodging | $1,572.97 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $4,360.53 | 6 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $4,360.53 | 6 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $2,271.85 | 13 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $1,422.56 | 40 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $1,422.56 | 40 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $1,258.58 | 8 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $741.78 | 5 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $614.15 | 9 | 2025 |
Source payment records
|
|||||
| R2P MISAGO Normalized: r2p misago |
Device | Terumo Medical Corporation | $450.00 | 1 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $391.09 | 3 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $322.41 | 2 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $299.02 | 4 | 2025 |
Source payment records
|
|||||
| Crosser IQ Normalized: crosser iq |
Device | Bard Peripheral Vascular, Inc. | $292.57 | 2 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $270.09 | 3 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $242.26 | 5 | 2025 |
Source payment records
|
|||||
| VISI-PRO Normalized: visi pro |
Device | Medtronic, Inc. | $215.26 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $189.73 | 7 | 2025 |
Source payment records
|
|||||
| ROSEN Normalized: rosen |
Device | Cook Medical LLC | $148.14 | 3 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $143.11 | 1 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $135.06 | 1 | 2025 |
Source payment records
|
|||||
| HELI-FX ENDOANCHOR SYSTEM Normalized: heli fx endoanchor system |
Device | Medtronic, Inc. | $134.00 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $114.65 | 4 | 2025 |
Source payment records
|
|||||
| Labosys Normalized: labosys |
Device | Philips North America LLC | $89.28 | 1 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $79.03 | 2 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $79.03 | 2 | 2025 |
Source payment records
|
|||||
| ZENITH ALPHA Normalized: zenith alpha |
Device | Cook Medical LLC | $67.50 | 1 | 2025 |
Source payment records
|
|||||
| CLOSUREFAST Normalized: closurefast |
Device | Medtronic, Inc. | $40.50 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $37.87 | 1 | 2025 |
Source payment records
|
|||||
| VENACORE THROMBECTOMY CATHETER Normalized: venacore thrombectomy catheter |
Device | Stryker Corporation | $28.69 | 2 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $20.67 | 2 | 2025 |
Source payment records
|
|||||
| BIOGLUE SURGICAL ADHESIVE Normalized: bioglue surgical adhesive |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
| PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM Normalized: photofix decellularized bovine pericardium |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
| Vascular Normalized: vascular |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
| INTHRILL THROMBECTOMY CATHETER Normalized: inthrill thrombectomy catheter |
Device | Stryker Corporation | $16.61 | 2 | 2025 |
Source payment records
|
|||||
| ZILVER VENA Normalized: zilver vena |
Device | Cook Medical LLC | $13.56 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 40 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 39 | 13 |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Eliquis | Apixaban | 21 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 17 | 12 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14,159.97 · 131 records | Stryker Corporation | ARTIX MT, Alto Abdominal Stent Graft System, BIOGLUE SURGICAL ADHESIVE, CLOSUREFAST, COLLAGENASE SANTYL, CT THROMBECTOMY SYSTEM KIT, Crosser IQ, ENDOCROSS Device, ENDURANT IIS, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, Flexitouch Plus, HELI-FX ENDOANCHOR SYSTEM, INTHRILL THROMBECTOMY CATHETER, Indigo System, LIMFLOW SYSTEM, LUTONIX Drug Coated Balloon, Labosys, Nimbl, PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM, Penumbra System, R2P MISAGO, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ROSEN, RotarexS 6 F x 135 cm, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TREO ABDOMINAL STENT-GRAFT SYSTEM, Torus Stent Graft System, VALIANT CAPTIVIA, VENACORE THROMBECTOMY CATHETER, VISI-PRO, Vascular, ZENITH ALPHA, ZENITH SPIRAL-Z, ZILVER VENA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error